CY1109701T1 - Συνθεση τροφης για ζωα - Google Patents

Συνθεση τροφης για ζωα

Info

Publication number
CY1109701T1
CY1109701T1 CY20091100813T CY091100813T CY1109701T1 CY 1109701 T1 CY1109701 T1 CY 1109701T1 CY 20091100813 T CY20091100813 T CY 20091100813T CY 091100813 T CY091100813 T CY 091100813T CY 1109701 T1 CY1109701 T1 CY 1109701T1
Authority
CY
Cyprus
Prior art keywords
animals
growth
disclosed
composition
derivative
Prior art date
Application number
CY20091100813T
Other languages
English (en)
Inventor
Hubert Jean Marie François Gillessen
Christian Rebiere
Original Assignee
Veijlen N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2003/011171 external-priority patent/WO2005039546A2/en
Application filed by Veijlen N.V. filed Critical Veijlen N.V.
Publication of CY1109701T1 publication Critical patent/CY1109701T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/132Heterocyclic compounds containing only one nitrogen as hetero atom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/168Steroids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/184Hormones
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/60Feeding-stuffs specially adapted for particular animals for weanlings
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/70Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75Feeding-stuffs specially adapted for particular animals for birds for poultry
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/80Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00Food or edible material: processes, compositions, and products
    • Y10S426/805Pet food for dog, cat, bird, or fish
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00Food or edible material: processes, compositions, and products
    • Y10S426/807Poultry or ruminant feed

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε μία σύνθεση τροφής για ζώα, η οποία περιλαμβάνει ελεύθερο οξικό οξύ ινδόλης (ελεύθερο ΙΑΑ) ή ένα παράγωγο αυτού. Η εφεύρεση επίσης αναφέρεται σε μία μέθοδο για ενίσχυση της ανάπτυξης των ζώων τρέφοντας το ζώο με μία σύνθεση σύμφωνα με την εφεύρεση. Η εφεύρεση επίσης αναφέρεται στη χρήση ελεύθερου ΙΑΑ ή ενός παραγώγου αυτού σε μία μέθοδο θεραπείας ζώων τα οποία χρειάζονται μία αγωγή για την προώθηση της ανάπτυξης τους, όπως σε ζώα με ανοσοανεπάρκεια, ζώα με ελλιπή ανάπτυξη ή ζώα με αργό ρυθμό ανάπτυξης. Η εφεύρεση επίσης αναφέρεται στη χρήση ελεύθερου ΙΑΑ ή ενός παραγώγου αυτού για την παρασκευή μίας θεραπευτικής σύνθεσης για την αύξηση του ρυθμού ανάπτυξης και/ή του ρυθμού μεταβολής της τροφής και/ή της ανοσίας ζώων που χρειάζονται μία τέτοια θεραπευτική αντιμετώπιση, ιδιαίτερα ζώων με ανοσοανεπάρκεια, ή αργή ανάπτυξη. Μία σύνθεση σύμφωνα με την εφεύρεση μπορεί κατά προτίμηση να είναι σε μορφή ενός τροφίμου ή συμπληρώματος διατροφής.
CY20091100813T 2003-10-03 2009-08-03 Συνθεση τροφης για ζωα CY1109701T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP2003/011171 WO2005039546A2 (en) 2003-10-03 2003-10-03 Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases
EP04765746A EP1667678B1 (en) 2003-10-03 2004-09-28 Animal feed composition
PCT/EP2004/010983 WO2005034942A1 (en) 2003-10-03 2004-09-28 Animal feed composition

Publications (1)

Publication Number Publication Date
CY1109701T1 true CY1109701T1 (el) 2014-08-13

Family

ID=39772852

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100813T CY1109701T1 (el) 2003-10-03 2009-08-03 Συνθεση τροφης για ζωα

Country Status (12)

Country Link
US (4) US20070184091A1 (el)
EP (1) EP1667678B1 (el)
JP (1) JP4762902B2 (el)
CN (1) CN1870992A (el)
AT (1) ATE430566T1 (el)
CA (1) CA2541126A1 (el)
CY (1) CY1109701T1 (el)
DE (1) DE602004021010D1 (el)
DK (1) DK1667678T3 (el)
PL (1) PL1667678T3 (el)
SI (1) SI1667678T1 (el)
WO (1) WO2005034942A1 (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2365847T3 (es) 2003-10-03 2011-10-11 Veijlen N.V. Uso de derivados del ácido indolacético que aumentan la concentración sérica de igf-1 para la preparación de una composición terapéutica para el tratamiento de diversas enfermedades.
EP1714673A1 (en) * 2005-04-21 2006-10-25 Desol BV Method for lengthening the mobility period of fish
EP1714674A1 (en) 2005-04-21 2006-10-25 Desol BV Method for improving the fertility of animals
ES2926021T3 (es) 2012-10-23 2022-10-21 Toolgen Inc Composición para escindir un ADN objetivo que comprende un ARN guía específico para el ADN objetivo y ácido nucleico codificador de proteína Cas o proteína Cas, y uso de la misma
CN104936591B (zh) * 2012-11-26 2018-05-29 国立大学法人东北大学 促红细胞生成素表达增强剂
EP3068235A4 (en) * 2013-11-15 2017-06-28 Archer Daniels Midland Company Methods of feeding animals fermentation cell mass
BR112017012792A2 (pt) * 2014-12-16 2018-01-02 Puretein Bioscience Llc métodos para aumentar a concentração de igf, para tratar uma condição, para melhorar ou manter a saúde e para melhorar uma característica
CN110169495A (zh) * 2019-07-04 2019-08-27 湖南师范大学 一种改善肠道免疫功能和肠道发育的饲料添加剂
WO2021055926A1 (en) * 2019-09-19 2021-03-25 Texas Tech University System Swine maternal neonatal pheromone
WO2023168022A1 (en) 2022-03-04 2023-09-07 Reset Pharmaceuticals, Inc. Co-crystals or salts comprising psilocybin
CN115624097B (zh) * 2022-08-31 2023-06-30 南京农业大学 一种促进幼龄反刍动物生长和瘤胃上皮发育的吲哚衍生物
CN118216609B (zh) * 2024-05-24 2024-08-09 潍坊新希望六和饲料科技有限公司 一种多肽在降低羔羊断奶应激反应的饲料添加剂中的应用

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2925341A (en) * 1956-02-04 1960-02-16 Bayer Ag Animal foodstuffs
US4025650A (en) 1975-11-24 1977-05-24 Control Drug, Inc. Method and composition for preventing nutritional deficiency
GB1475861A (en) 1976-03-19 1977-06-10 Warner Lambert Co Pharmaceutical composition
GB1535778A (en) 1976-12-06 1978-12-13 Mac Sweeney D Compounds useful in treatment of unipolar depression
JPS60161920A (ja) * 1984-01-31 1985-08-23 Masaki Kamata 動物用成長剤
JPS60199801A (ja) * 1984-03-24 1985-10-09 Masaki Kamata 動物に対する植物成長ホルモンの投与方法
US4687763A (en) 1985-02-25 1987-08-18 Massachusetts Institute Of Technology Composition and method for increasing levels or release of brain serotonin
US4650789A (en) 1985-10-15 1987-03-17 Commonwealth Medical Corporation Of America Method and composition for increasing production of serotonin
GB8727099D0 (en) 1987-11-19 1987-12-23 Cellena Cell Eng A G Compositions containing melantonin/homologues
US4945103A (en) 1989-01-17 1990-07-31 Michael Cohen Method of treating pre-menstrual syndrome
IT1237472B (it) 1989-10-04 1993-06-07 Polifarma Spa Derivati di acido 3-indolpiruvico, loro procedimento di produzione ed impiego terapeutico.
US5132113A (en) 1990-10-26 1992-07-21 Maurizio Luca Nutritional composition containing essential amino acids
PT100973A (pt) 1991-10-18 1994-06-30 Alza Corp Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica
GB9214419D0 (en) 1992-07-07 1992-08-19 Concannon Peter Biocidal agents
FR2746313B1 (fr) 1996-03-22 1998-04-17 Adir Utilisation de la melatonine et des ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention et au traitement du diabete et des complications diabetiques
US5958964A (en) 1997-02-18 1999-09-28 South Alabama Medical Science Foundation Use of melatonin to prevent cytotoxic effects of amyloid beta protein
DE19739763A1 (de) 1997-09-10 1999-09-23 Franz Uhl Vitamin B3/Niacin zur Behandlung von Krankheiten
US6017946A (en) 1997-10-08 2000-01-25 Posner; Robert Serotonin containing formulation for oral administration and method of use
CN1069050C (zh) 1998-12-01 2001-08-01 周旭生 一种治疗糖尿病的中药复方制剂
DE69922997T2 (de) 1998-12-04 2005-12-15 Neurosearch A/S Verwendung von isatinderivaten als ionenkanalaktivierende mittel
FR2795323B1 (fr) 1999-06-23 2001-11-16 Adir Utilisation de ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention ou au traitement des pathologies du systeme gastrointestinal
JP2001026579A (ja) * 1999-07-13 2001-01-30 Kobe Tennenbutsu Kagaku Kk インドール酢酸類の製造方法
US20020155163A1 (en) 1999-12-27 2002-10-24 Samuel D. Benjamin Integrated multi-vitamin and mineral combination
WO2001064205A2 (en) 2000-03-02 2001-09-07 The Institutes For Pharmaceutical Discovery, Llc Compositions containing a substituted indolealkanoic acid and an angiotensin converting enzyme inhibitor
DE10109798A1 (de) 2001-03-01 2002-09-12 Aventis Pharma Gmbh Gesundheitsfördernde Zusammensetzung von Verbindungen
JP2002281914A (ja) * 2001-03-27 2002-10-02 Nishi Nippon Green Kk 魚類、家畜類の栄養活力促進剤の製造方法
US20020147155A1 (en) 2001-04-06 2002-10-10 Foster Warren G. Prevention and treatment of endometriosis with aryl hydrocarbon receptor binding ligands
CN1408397A (zh) 2001-09-26 2003-04-09 北京本元青阳生物科技发展有限公司 含褪黑素和益智中药的组合物
US6933316B2 (en) * 2001-12-13 2005-08-23 National Health Research Institutes Indole compounds
US20040067918A1 (en) 2002-03-18 2004-04-08 Keller Bradley T. Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative
CN1440744A (zh) 2003-02-15 2003-09-10 高景曦 纳米包覆退黑激素复合保健品
ES2365847T3 (es) 2003-10-03 2011-10-11 Veijlen N.V. Uso de derivados del ácido indolacético que aumentan la concentración sérica de igf-1 para la preparación de una composición terapéutica para el tratamiento de diversas enfermedades.

Also Published As

Publication number Publication date
JP2007507213A (ja) 2007-03-29
DK1667678T3 (da) 2009-08-24
PL1667678T3 (pl) 2009-10-30
CN1870992A (zh) 2006-11-29
WO2005034942A1 (en) 2005-04-21
SI1667678T1 (sl) 2009-12-31
CA2541126A1 (en) 2005-04-21
EP1667678B1 (en) 2009-05-06
US20120283308A1 (en) 2012-11-08
US20070184091A1 (en) 2007-08-09
EP1667678A1 (en) 2006-06-14
ATE430566T1 (de) 2009-05-15
US8883233B2 (en) 2014-11-11
DE602004021010D1 (de) 2009-06-18
US20110196013A1 (en) 2011-08-11
JP4762902B2 (ja) 2011-08-31
US20150038544A1 (en) 2015-02-05

Similar Documents

Publication Publication Date Title
CY1109701T1 (el) Συνθεση τροφης για ζωα
WO2006041903A3 (en) A method of cultivating animals to develop a desired color and to increase their rate of growth
MX340752B (es) Composiciones de alimento para animales de acido abscisico.
EA201270201A1 (ru) Липкий мягкий гель для обработки домашних птиц
UA95734C2 (ru) Применение эдта и ее солей для профилактики и лечения бактериальных кишечных заболеваний свиней и усиления эффектов антибиотиков, которые выявляются при подобных заболеваниях
CN104585100A (zh) 一种白虾的高产养殖方法
CN104255641A (zh) 一种生猪饲养方法
MX343468B (es) Proceso para elaborar una sal de zilpaterol cristalina.
CN102870811A (zh) 一种畜禽养殖环境消毒剂
CN104351585A (zh) 架子牛育肥饲料及其应用
MX2009008888A (es) Metodos para acelerar el desarrollo muscular, disminuir los depositos de grasa y mejorar la eficiencia alimenticia en cerdos.
RU2008124216A (ru) Способ лечения и профилактики фасциолеза коров
MX2023009381A (es) Alimento para ganado.
MX2010008038A (es) Composiciones para alimentar animales.
NO20070660L (no) Anvendelsen av paeonia og ekstrakter derav med vekstfremmende aktivitet i veterinaer medisin og zooteknikk
EE200300406A (et) Meetod loomasööda lisandina kasutatava D-pantoteenhappe ja/või tema soolade saamiseks
NZ590609A (en) The use of sandalwood extracts and analogues as animal food additives
RU2541650C1 (ru) Способ приготовления кормовой добавки из каныги для откорма рыб
EE200300405A (et) Meetod loomasööda lisandina kasutatava D-pantoteenhappe ja/või tema soolade saamiseks
NO20070661L (no) Anvendelsen av medisinske planter og ekstrakter derav for dyrs velvaere i veterinaer medisin og zooteknikk
TW200806191A (en) Feed additive
RU2008111823A (ru) Способ кормления быков-производителей новой мясной породы "русская комолая"
RU2009141760A (ru) Способ лечения респираторных болезней молодняка сельскохозяйственных животных
Зубкова EFFECTIVENESS OF FATTENING PIGS BY USING AROMA ADDITIVES" CARAMEL-VANILLA"
UA42175U (ru) Способ повышения интенсивности роста молодняка свиней на откорме